The overall goal of this study is to identify interference between intramuscular Inactivated
Polio Vaccine (IPV) and other vaccines (Measles Rubella and Yellow Fever) co-administered at
nine months of age and to confirm the safety of co-administration. In addition, the study
will compare the immunogenicity and safety of IPV when administered via different routes.
A total of 1504 healthy infants between the ages of nine to ten months, who have completed
their primary immunizations, including at least three doses of trivalent Oral Polio Vaccine
(tOPV) will be recruited for this study.
Phase:
Phase 4
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine Medical Research Council Unit, The Gambia